Check out CATIE’s HepC Info Update 3.5:
- Hepatitis C advocates call for early studies of interactions with new hepatitis C virus drugs
- Drug users’ union in San Francisco seeks voice in policy
- Hepatitis C in baby boomers remains silent epidemic
- FDA Drug Safety Communication: Interactions between certain HIV or hepatitis C drugs and cholesterol-lowering statin drugs can increase the risk of muscle injury
- Telaprevir and boceprevir improve sustained virological response rates in people co-infected with HIV/hepatitis C
- Study shows how interferon fights HIV along with hepatitis C in people who are co-infected
As well as:
- Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: A systematic review and meta-Analysis – Liver Transplantation, March 2012, in English
- Case-control study of hepatitis B and hepatitis C in older adults: Do healthcare exposures contribute to burden of new infections? – Hepatology, March 2012, in English
- Peg-interferon for chronic hepatitis C in children affects growth and body composition: Results from the pediatric study of hepatitis C (PEDS-C) trial – Hepatology, March 2012, in English
- Future treatment of patients with hepatitis C virus cirrhosis – Liver International, February 2012, in English
View the full update here.